122 related articles for article (PubMed ID: 2606377)
41. Effect of an anti-ulcer agent, 2'-carboxymethoxy-4, 4'-bis (3-methyl-2-butenyloxy) chalcone (SU-88), on the biosynthesis of gastric sulfated mucosubstances in restrained and water-immersed rats.
Suwa T; Fukushima K; Kyogoku K; Edo H; Mori Y
Jpn J Pharmacol; 1984 Jan; 34(1):89-94. PubMed ID: 6716720
[TBL] [Abstract][Full Text] [Related]
42. Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats.
Shimohara K; Niida H; Okabe S
Jpn J Pharmacol; 1990 Jun; 53(2):275-9. PubMed ID: 2385012
[TBL] [Abstract][Full Text] [Related]
43. A novel in vitro effect of the mucosal protective agent sofalcone--inhibition of chemotactic motility in Helicobacter pylori.
Yoshiyama H; Nakamura H; Okamoto T; Okita K; Nakazawa T
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():230-6. PubMed ID: 10807429
[TBL] [Abstract][Full Text] [Related]
44. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
[TBL] [Abstract][Full Text] [Related]
45. Enzymatic sulfation of gastric mucous glycoprotein in rat--changes in glycoprotein sulfotransferase activity with stress and anti-ulcer agent, sofalcone.
Murakami S; Muramatsu M; Aihara H; Honda A; Mori Y
Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):77-98. PubMed ID: 3478774
[TBL] [Abstract][Full Text] [Related]
46. Effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone (SU-88) on gastric local blood flow.
Matsuo Y; Seki A; Yakabi K; Saziki R; Arai I; Isobe Y; Aihara H
Arzneimittelforschung; 1983; 33(2):242-3. PubMed ID: 6682663
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic effect of egualen sodium (KT1-32), a new antiulcer agent, on chronic gastritis induced by sodium taurocholate in rats.
Mochizuki S; Matsumoto M; Wakabayashi S; Kosakai K; Tomiyama A; Kishimoto S
J Gastroenterol; 1996 Dec; 31(6):785-92. PubMed ID: 9027640
[TBL] [Abstract][Full Text] [Related]
48. Sofalcone for treatment of Helicobacter pylori infection.
Fujioka T; Murakami K; Kubota T; Kodama R; Honda S; Nasu M
J Gastroenterol; 1996 Nov; 31 Suppl 9():56-8. PubMed ID: 8959521
[TBL] [Abstract][Full Text] [Related]
49. Epithelial cell proliferation in human fundic and antral mucosae. Influence of superselective vagotomy and relationship with gastritis.
Gutierrez O; Lehy T; René E; Grès L; Bonfils S
Dig Dis Sci; 1985 Nov; 30(11):1034-42. PubMed ID: 4053914
[TBL] [Abstract][Full Text] [Related]
50. Lipolytic activity of Campylobacter pylori: effect of sofalcone.
Slomiany BL; Nishikawa H; Piotrowski J; Okazaki K; Slomiany A
Digestion; 1989; 43(1-2):33-40. PubMed ID: 2806755
[TBL] [Abstract][Full Text] [Related]
51. Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
Kodama R; Fujioka T; Fujiyama K; Kawasaki H; Kubota T; Nasu M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S125-8. PubMed ID: 7735929
[TBL] [Abstract][Full Text] [Related]
52. [Turnover of the superficial epithelial cells of the gastric mucosa].
Sasaki Z; Murakami M; Misaki F; Kawai K
Nihon Rinsho; 1984 Jan; 42(1):95-102. PubMed ID: 6716680
[No Abstract] [Full Text] [Related]
53. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
54. Prostaglandin cytoprotection linked to the adhesion of mucous glycoprotein to the gastric epithelium.
Murakami S; Fujimoto N; Mori Y
J Pharmacobiodyn; 1986 Apr; 9(4):359-67. PubMed ID: 3461154
[TBL] [Abstract][Full Text] [Related]
55. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
56. Effect of misoprostol and cimetidine on gastric cell turnover.
Fich A; Arber N; Sestieri M; Zajicek G; Rachmilewitz D
Dig Dis Sci; 1985 Nov; 30(11 Suppl):133S-135S. PubMed ID: 3932045
[TBL] [Abstract][Full Text] [Related]
57. [Sofalcone].
Fukuda Y; Shimoyama T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():704-9. PubMed ID: 11979875
[No Abstract] [Full Text] [Related]
58. Effects of single parenteral indomethacin injection in rat fundic and antral epithelial proliferation.
Kuwayama H; Nakajima N; Matsuo Y; Eastwood GL
J Clin Gastroenterol; 1990; 12 Suppl 1():S72-5. PubMed ID: 2212552
[TBL] [Abstract][Full Text] [Related]
59. Cell proliferation in normal and diseased gastric mucosa. Autoradiography after in vitro continuous labelling with tritiated thymidine.
Hart-Hansen O; Johansen A; Larsen JK; Svendsen LB
Acta Pathol Microbiol Scand A; 1979 May; 87A(3):217-22. PubMed ID: 463568
[TBL] [Abstract][Full Text] [Related]
60. The possible role of vascular endothelial growth factor (VEGF) in gastric ulcer healing: effect of sofalcone on VEGF release in vitro.
Takahashi M; Maeda S; Ogura K; Terano A; Omata M
J Clin Gastroenterol; 1998; 27 Suppl 1():S178-82. PubMed ID: 9872518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
